23.10.2018 - 25.10.2018Seaport Hotel, 1 Seaport Lane, 02210 Boston, USA
Time: 8:00 am to 5:00 pm
Conference themes As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 is a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class.
Focus on understanding the selectivity and speed of binding, improve the rationale design of bifunctional molecules and overcome critical chemistry challenges.
Professional congress organizer (PCO) Hanson Wade
Notes Speakers: Craig Crews (Yale University), Alexandra Glucksmann (Cedilla Therapeutics), John Houston (Arvinas), Laurent Audoly (Kymera Therapeutics), John Harling (GSK), Brian Jones (Cedilla Therapeutics)